Flora Growth (FLGC) Stock Price, News & Analysis

Company Overview

Flora Growth is a diversified agriculture and cannabis company focused on the research, development and commercialization of cannabinoid-based products. Operating under a fully integrated business model, the company cultivates proprietary strains, extracts active compounds and manufactures finished goods for both medical and wellness markets. By leveraging advanced agritech practices and proprietary extraction methods, Flora Growth aims to optimize yield, safety and consistency across its product lines.

The company’s portfolio encompasses a broad range of offerings, including tinctures, topical creams, soft gels and pure cannabidiol (CBD) powders. In addition to its consumer brands, Flora Growth provides white-label and private-label manufacturing services for third-party partners. Its in-house research and development teams focus on formulation science, process optimization and the exploration of lesser-known cannabinoids, positioning Flora Growth at the forefront of product innovation in the evolving cannabis space.

Flora Growth serves markets across North and Latin America, with cultivation facilities in Colombia and Canada. The company also operates e-commerce platforms targeting key markets in the United States and Europe. By combining its international cultivation infrastructure with global distribution channels, Flora Growth seeks to address varying regulatory frameworks and consumer preferences while ensuring product accessibility and regulatory compliance in each jurisdiction.

Founded by a team of agricultural scientists and industry veterans, Flora Growth is led by CEO Hans Hillebrand, whose background spans biotechnology, pharmaceuticals and supply-chain management. Under his leadership, the company has expanded its footprint through strategic partnerships and investments in research collaborations. Flora Growth’s management emphasizes transparency, quality control and sustainable cultivation practices as pillars of its long-term growth strategy in the competitive cannabinoid market.

Key Stats

• Today's Range: $0.62 to $0.67
• 50-Day Range: $0.58 to $0.78
• 52-Week Range: $0.42 to $2.11
• Volume: 173,172 shs
• Average Volume: 274,696 shs
• Market Capitalization: $13.99 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: Moderate Buy

Flora Growth Stock Analysis - MarketRank™

Flora Growth scored higher than 34% of companies evaluated by MarketBeat, and ranked 723rd out of 918 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Flora Growth has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Flora Growth has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Flora Growth are expected to grow in the coming year, from ($0.93) to ($0.18) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Flora Growth is -0.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Flora Growth is -0.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Flora Growth has a P/B Ratio of 2.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.57% of the float of Flora Growth has been sold short.

Short Interest Ratio / Days to Cover

Flora Growth has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Flora Growth has recently increased by 75.74%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Flora Growth does not currently pay a dividend.

Dividend Growth

Flora Growth does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.57% of the float of Flora Growth has been sold short.

Short Interest Ratio / Days to Cover

Flora Growth has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Flora Growth has recently increased by 75.74%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

1 people have added Flora Growth to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Flora Growth insiders have not sold or bought any company stock.

Percentage Held by Insiders

12.56% of the stock of Flora Growth is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 36.01% of the stock of Flora Growth is held by institutions.

FLGC Stock Analysis - Frequently Asked Questions

How have FLGC shares performed this year?

Flora Growth's stock was trading at $1.03 at the start of the year. Since then, FLGC shares have decreased by 39.8% and is now trading at $0.62.

How were Flora Growth's earnings last quarter?

Flora Growth Corp. (NASDAQ:FLGC) announced its earnings results on Tuesday, May, 13th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.03. The business had revenue of $11.79 million for the quarter, compared to analyst estimates of $14.79 million. Flora Growth had a negative trailing twelve-month return on equity of 216.49% and a negative net margin of 24.85%.

When did Flora Growth's stock split?

Flora Growth shares reverse split on Friday, June 9th 2023.The 1-20 reverse split was announced on Friday, June 9th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 9th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Flora Growth IPO?

Flora Growth (FLGC) raised $15 million in an IPO on Tuesday, May 11th 2021. The company issued 3,300,000 shares at $4.00-$5.00 per share. Boustead Securities acted as the underwriter for the IPO.

How do I buy shares of Flora Growth?

Shares of FLGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Flora Growth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Flora Growth investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Tesla (TSLA), NIO (NIO) and

Company Calendar

• Last Earnings: 5/13/2025
• Today: 7/21/2025
• Next Earnings (Estimated): 8/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:FLGC
• CIK: 1790169
• Web: floragrowth.ca
• Phone: 954-842-4989
• Fax: N/A
• Employees: 280
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Flora Growth: $4.00
• High Price Target: $4.00
• Low Price Target: $4.00
• Potential Upside/Downside: +545.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.98)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$15.91 million
• Net Margins: -24.85%
• Pretax Margin: -25.46%
• Return on Equity: -216.49%
• Return on Assets: -45.56%

Debt

• Debt-to-Equity Ratio: 0.88
• Current Ratio: 1.05
• Quick Ratio: 0.67

Sales & Book Value

• Annual Sales: $59.51 million
• Price / Sales: 0.24
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.31 per share
• Price / Book: 2.00

Miscellaneous

• Outstanding Shares: 22,570,000
• Free Float: 19,734,000
• Market Cap: $13.99 million
• Optionable: Not Optionable
• Beta: 1.97